News

2017

company

year

domain

Codiak BioSciences Closes $76.5 Million Series C Financing

11.29.2017

Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination

Moderna 11.27.2017

Indigo Corn™ Demonstrates Significant Yield Gains on Farms Experiencing Severe Water Stress

Indigo Agriculture 11.20.2017

Evelo Biosciences and Mayo Clinic Collaborate to Advance Monoclonal Microbials for the Treatment of Inflammatory and Neuroinflammatory Diseases

Evelo Biosciences 11.16.2017

Flagship Pioneering Names David Perry, CEO of Indigo Agriculture, as Recipient of the 2017 Pioneering Leader Award

Flagship Pioneering 11.16.2017

Moderna Announces First-in-Human Dosing for Phase 1 Study (KEYNOTE-603) of mRNA-4157, a Personalized Cancer Vaccine, for the Treatment of Solid Tumors

Moderna 11.15.2017

Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team

11.14.2017

Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology

Seres Therapeutics 11.14.2017

Syros Announces Appointment of Jeremy P. Springhorn as Chief Business Officer

Syros Pharmaceuticals 11.13.2017

Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells

Moderna 11.13.2017

Loading